article information

Interventional Pain Medicine and Neuromodulation: Vol.2, issue 1; e134759
published online: January 15, 2023
article type: Letter
received: January 6, 2023
accepted: January 6, 2023
DOI: https://doi.org/10.5812/ipmn-134759
Crossmark

An Overview of Published Articles in the Interventional Pain Medicine and Neuromodulation Journal in 2022

authors:

avatar Mozhgan Alipour 1 , avatar Alireza Zali ORCID 1 , *

Functional Neurosurgery Research Center, Shohada Tajrish Comprehensive Neurosurgical Center of Excellence, Shahid Beheshti University of Medical Sciences, Tehran, Iran

how to cite: Alipour M, Zali A. An Overview of Published Articles in the Interventional Pain Medicine and Neuromodulation Journal in 2022. Interv Pain Med Neuromod. 2022;2(1):e134759. https://doi.org/10.5812/ipmn-134759.

Dear Editor,

Neuromodulation is an exciting and expanding field of pain medicine, which includes a variety of non-invasive methods, such as electromagnetic fields, invasive electrical and surgical treatments, and pharmacological agents or disruption of pathways. Due to the importance of the topic, our journal started to publish related topics since 2021. In this editorial, we present a report of our publications in 2022 to identify our strengths and weaknesses and provide readers and writers with a brief report of our performance, which may help them get to know the journal better.

We published 15 articles from various countries in 2022. The published papers are indexed in EBSCO, Index Copernicus, Open-J-Gate, DRJI, and, CiteFactor, and very soon, they will be indexed in PubMed. Just like the previous year, the articles were published in five categories: Original articles (three articles), case reports (four articles), review articles (three articles), and letters to the editor (five articles). In 2021, the number of original articles was one article (1), the number of case reports was two articles (2, 3), the number of review articles was three articles (4-6), and the number of editorials and letters to the editor was 11 articles (7-17). Compared to last year, the number of letters and editorials reduced, and the number of original articles and case reports increased.

All the published articles complied with the journal's scope and matched the field of neuromodulation and pain. Also, the aspect of innovation and the subject's newness were considered. For example, the paper titled "Neurobiophysics and Strategies in Neural Stimulation" was submitted by Alipour and Hajipour-Verdom, which has a fundamental strategy for neuromodulation (7).

Due to the critical role of artificial intelligence (AI) in various aspects of science, this topic was deemed a “hot topic” and articles on the role of AI in various aspects of studies related to the nervous system were prioritized for review and publication. The paper titled “Artificial Intelligence and Migraine: Insights and Applications” was submitted by Shaterian et al., which examined the role of AI in diagnosing and treating migraine as a common disease with a moderate or severe headache (18).

One of the strong points of this journal is the short time of the refereeing and publication process. Also, in this journal, the editorial board, advisory board, and consultants have been invited to cooperate in various scientific fields, which has improved the quality of accepted articles. Moreover “case report” is an inseparable part of our journal, which is always welcomed by many authors with different levels of experience in medical research, from medical students to renowned professors. The papers titled “Bilateral Lumbar Erector Spinae Plane Block for Pain Control in Open Ureteric Repair and Reimplant: A Case Report” and “Biomarker of Urinary Malondialdehyde and Tumor Necrosis Factor-Alpha with Pain Progress in a Patient with Low Back Pain” are two examples of articles in the field of pain control that was published (19, 20).

Our goal in this journal is to play a role, however small, in helping physicians practice medicine, which can improve the public health of all communities. For this reason, we will publish articles that, in addition to innovation, lead to the improvement of treatment methods for diseases related to the nervous system. Also, we would like to thank all the authors who have helped us along this path.

References

  • 1.

    Sabbaghzadeh A, Behnaz F, Aslani H, Ghasemi M. Comparison of the Effect of Dexamethasone and Ketorolac on Pain Control in Elective Foot Surgery. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.117516.

  • 2.

    Mousavi E, Mohseni M. Respiratory Failure Following Interscalene Block for the Treatment of Shoulder Dislocation in a Patient with COVID-19. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.117577.

  • 3.

    Ebnerasouli S, Aminnejad R, Hoseini Amini MR, Zeynolabedin SM. To Stay Safe Walking, Follow the Rules of the Road: Anesthesia for Cesarean Section in the Setting of Myocardial Infarction, a Case Report. Interv Pain Med Neuromod. 2022;1(1). https://doi.org/10.5812/ipmn.116357.

  • 4.

    Maqbool M, Zehravi M. Neuroprotective Role of Polyphenols in Treatment of Neurological Disorders: A Review. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.117170.

  • 5.

    Hashemi M, Momenzadeh S, Taheri M, Rajaei S. The Importance of Sacral Neuroanatomy in Pain Syndromes and Procedures. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.116625.

  • 6.

    Farzin H, Sakha H, Eslahi R. The Brief Review on Telemedicine: New Dream in Developing Countries. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.115506.

  • 7.

    Alipour M, Hajipour-Verdom B. Neurobiophysics and Strategies in Neural Stimulation. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.115521.

  • 8.

    Momenilandi F, Tehrani Fateh S. Deep Brain Stimulation In Iran: Where It Began and Where It Goes. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.119355.

  • 9.

    Aminnejad R, Aryani MR. IPACK Block as a Bridge for New Treatment Modalities of Knee Osteoarthritis. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.115222.

  • 10.

    Matis G. Big Data and Chronic Pain: A New Era for Neuromodulation? Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.114140.

  • 11.

    Safari S, Zali A, Akhlaghdoust M, Pezeshgi P. Iran’s Scientific Publications on Neuromodulation. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.115244.

  • 12.

    Rayegani SM. Pain and Neuromodulation. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.118842.

  • 13.

    Aminnejad R. Love as an Analgesic. Interv Pain Med Neuromod. 2022;1(1). https://doi.org/10.5812/ipmn.115487.

  • 14.

    Pirmohamadi H, Rahmati Roodsari S, Arab-Mazar Z, Rahimi M. Pain Management After Total Knee Arthroplasty. Interv Pain Med Neuromod. 2022;1(1). https://doi.org/10.5812/ipmn.119944.

  • 15.

    Matis G. Spinal Cord Stimulation – New Technical Advancements. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.117725.

  • 16.

    Hashemi M, Aminnejad R, Rajaei S. Evolution of Interventional Pain Management and Its Barriers in Developing Countries. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.115716.

  • 17.

    Eftekharian S, Zali A, Rahmati Roodsari S, Pirmohamadi H, Arab-Mazar Z, Rahimi M. Pain Management Strategies and Improving Comfort in Orthodontics. Interv Pain Med Neuromod. 2021;1(1). https://doi.org/10.5812/ipmn.117324.

  • 18.

    Shaterian N, Soltani A, Samieefar N, Akhlaghdoust M. Artificial Intelligence and Migraine: Insights and Applications. Interv Pain Med Neuromod. 2022;2(1). https://doi.org/10.5812/ipmn-127675.

  • 19.

    Angeletti C, De Martinis G, D'Agostino ML, Carrocci C, Scimia P, Marinangeli F. Bilateral Lumbar Erector Spinae Plane Block for Pain Control in Open Ureteric Repair and Reimplant: A Case Report. Interv Pain Med Neuromod. 2022;2(1). https://doi.org/10.5812/ipmn-128558.

  • 20.

    Seydi H, Hassanpourezatti M. Biomarker of Urinary Malondialdehyde and Tumor Necrosis Factor-Alpha with Pain Progress in a Patient with Low Back Pain. Interv Pain Med Neuromod. 2022;2(1). https://doi.org/10.5812/ipmn-129275.